Table 2.
Multiple comparisons of left hippocampal NAA.
| Group | Mean | SD | p | 95% confidence interval | ||
|---|---|---|---|---|---|---|
| Lower limit | Upper limit | |||||
| DR | T2DM | -8.12260* | 3.56952 | 0.026* | −15.2494 | −0.9958 |
| HC | -15.29449* | 3.54425 | 0.000* | −22.3708 | −8.2182 | |
| T2DM | DR | 8.12260* | 3.56952 | 0.026* | 0.9958 | 15.2494 |
| HC | -7.17189* | 3.08675 | 0.023* | −13.3348 | −1.0090 | |
| HC | DR | 15.29449* | 3.54425 | 0.000* | 8.2182 | 22.3708 |
| T2DM | 7.17189* | 3.08675 | 0.023* | 1.0090 | 13.3348 | |
*
The left hippocampal NAA were compared between any two groups, p <0.05, the difference was statistically significant. T2DM, Type 2 diabetes mellitus; DR, diabetic retinopathy; NAA, Nacetylaspartate.